Surgical Management of Subretinal Hemorrhage
Yıl: 2020 Cilt: 29 Sayı: 1 Sayfa Aralığı: 1 - 9 Metin Dili: İngilizce DOI: 10.37845/ret.vit.2020.29.1 İndeks Tarihi: 20-05-2021
Surgical Management of Subretinal Hemorrhage
Öz: Large submacular hemorrhage, an uncommon manifestation of neovascular age-related macular degeneration. Submacular hemorrhage damagesphotoreceptors due to iron toxicity and reduced nutrient fl ux. Multiple treatment modalities have been suggested including intravitrealanti-vascular endothelial growth factor injections, pneumatic displacement with or without adjuvant intravitreal tissue plasminogen activator,and pars plana vitrectomy with or without adjuvant subretinal tissue plasminogen activator, macular translocation or RPE-choroidal patch graft.While no consensus exists, the preferred technique is often determined by the extent or duration of the hemorrhage and surgeon preference. Inthis review, surgical treatments will be discussed in submacular hemorrhage.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editoryal Erişim Türü: Bibliyografik
- 1. Hochman M, Seery C, Zarbin M. Pathophysiology and management of subretinal haemorraghe. Surv Ophthalmol 1997;41:195-213.
- 2. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol. 1996; 122:486-93.
- 3. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762-773.
- 4. Scupola A, Cosca G, Soubrane G, et al. Natural history ofmacular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213:97-102.
- 5. Hassan AS, Johnson MW, Schneiderman TE, ve ark. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106:1900-6.
- 6. Balughatta P, Kadri V, Braganza S, ve ark. Pneumatic displacement of limited traumatic submacular hemorrhage without tissue plasminogen activator: a case series. Retin Cases Brief Rep. 2019;13:34.
- 7. Toth CA, Morse LS, Hjelmeland LM, ve ark. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol. 1991;109:723-9.
- 8. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol. 1996;122:486-93.
- 9. Viestenz A. Rupture of the choroid after eyeball contusion— an analysis based on the Erlangen Ocular Contusion Registry (EOCR). Klin Monbl Augenheilkd. 2004;221:713- 9.
- 10. Malik FF, Poulaki V. Management of submacular hemorrhage. Int Ophthalmol Clin. 2014;54:51-9.
- 11.Stanescu-Segall D, Balta F, Jackson TL. Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature. Surv Ophthalmol 2016; 61 (1): 18-32.
- 12. Yiu G, Mahmoud TH. Subretinal hemorrhage. Dev Ophthalmol 2014; 54: 213-22.
- 13. Fine HF, Iranmanesh R, Del Priore LV, ve ark. Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration. Retina 2010; 30 (10): 1588-94.
- 14. Chang W, Garg SJ, Maturi R Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol 2014; 157 (6): 1250-7.
- 15. Avery RL, Fekrat S, Hawkins BS, ve ark. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16:183-9.
- 16. Bennet SR, Folk JC, Blodi CF, ve ark. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol. 1990;109:33-7.
- 17. Schulze SD, Hesse L. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: Predictive variable for visual outcome. Graefes Arch Clin Exp Ophthalmol 2002;240: 717-20.
- 18. Lewis H. Intraoperative fi brinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol. 1994;118:559-68.
- 19. Hattenbach LO, Klais C, Koch FH, ve ark. Intravitreous injection of tissue plaminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmol 2001;108:1485-92.
- 20. Kiernan D, Hariprasad S, Rusu I, ve ark. Epidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration. Retina 2010;30:1573-8.
- 21. Maclaren RE, Bird AC, Sathia PJ, ve ark. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. 2005;112:2081e7
- 22. Heriot WJ. Pre American Academy of Ophthalmology meeting, Chicago, IL, 1996.
- 23. Chen CY, Hooper C, Chiu D, ve ark. Management of submacular hemorrhage with intravitreal injection of tissue of tissue plasminogen activator and expansile gas. Retina 2007; 27:321-8.
- 24. Ohji M, Saito Y, Hayashi A, ve ark. Pneumatic dis- placement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998;116:1326-32.
- 25. Gopalakrishan M, Giridhar A, Bhat S, ve ark. Pneumatic displacement of submacular hemorrhage: Safety, effi cacy, and patient selection. Retina. 2007 Mar; 27(3):329-34.
- 26. Cakir M, Cekic O, Yilmaz O. Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator. Eur J Ophthalmol 2010; 20:565-71.
- 27. Haupert CL, Mccuen BW, Jaffe GJ, ve ark. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fl uid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. 2001;131:208e15
- 28. Martel JN, Mahmoud TH. Subretinal pneumatic displacement of subretinal hemorrhage. JAMA Ophthalmol. 2013;131:1632e5
- 29. Kapran Z., Ozkaya A., Uyar O.M. Hemorrhagic age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, gas tamponade, and upright positioning. Ophthalmic Surg Lasers Imag Retina. 2013;44:471-6.
- 30. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. 1999;237:273e7
- 31. Buschini E, Iannetta D, Lesnik Oberstein SY, ve ark. Subretinal versus intravitreal injection of recombinant tissue plasminogen activator in post-traumatic submacular haemorrhages. Acta Ophthalmol. 2016;94:307-9.
- 32. Hillenkamp J, Surguch V, Framme C, ve ark. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. 2010;248:5-11.
- 33. Johnson MW. Pneumatic displacement of submacular hemorrhage. Curr Opin Ophthalmol. 2000;11:201e6
- 34.Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina. 1991;11:250e8
- 35. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: Ii. A surgical approach for agerelated macular degeneration? Graefes Arch Clin Exp Ophthalmol. 1993;231:635e41
- 36. Wong D, Stanga P, Briggs M, ve ark. Case selection in macular relocation surgery for age related macular degeneration. Br J Ophthalmol. 2004;88:186e90
- 37.Abdel-Meguid A, Lappas A, Hartmann K, ve ark. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol. 2003;87:615e21
- 38. Boyer DS, Antoszyk AN, Awh CC, ve ark. Subgroup analysis of the marina study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007;114:246e52
- 39. Panda-Jonas S, Jonas JB, Jakobczyk-Zmija M. Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes. Am J Ophthalmol. 1996;121:181e9
- 40. Acheampong P, Ford GA. Pharmacokinetics of alteplase in the treatment of ischaemic stroke. Expert Opin Drug Metab Toxicol. 2012;8:271e81
- 41. Bressler NM, Bressler SB, Childs AL, ve ark. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic fi ndings: sst report no. 13 Ophthalmology. 2004;111:1993e2006
- 42. Peyman GA, Blinder KJ, Paris CL, ve ark. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991;22:102e8
- 43. Bressler NM, Hawkins BS, Sternberg PJ, ve ark. Are the submacular surgery trials still relevant in an era of photodynamic therapy? Ophthalmology. 2001;108:435e6
- 44. Joussen AM, Heussen FM, Joeres S, ve ark. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol. 2006;142:17e30
- 45. Treumer F, Bunse A, Klatt C, ve ark. Autologous retinal pigment epithelium-choroid sheet transplantation in age related macular degeneration: morphological and functional results. Br J Ophthalmol. 2007;91:349e53
- 46. Van Meurs JC, Van Den Biesen PR. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: shortterm follow- up. Am J Ophthalmol. 2003;136:688e95
- 47. Parolini B, Di Salvatore A, Pinackatt SJ, ve ark. Long Term Results of autologous retinal epithelium and choroid transplantation fort he treatment of exudative and atrophic maculopathies. Retina. 2018 Dec 31.10.1097
- 48. Lewis H, Sloan SH, Foos RY. Massive intraocular hemorrhage associated with anticoagulation and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1988;226:59-64.
| APA | James B, KARABAŞ V (2020). Surgical Management of Subretinal Hemorrhage. , 1 - 9. 10.37845/ret.vit.2020.29.1 |
| Chicago | James Braydon,KARABAŞ V. Levent Surgical Management of Subretinal Hemorrhage. (2020): 1 - 9. 10.37845/ret.vit.2020.29.1 |
| MLA | James Braydon,KARABAŞ V. Levent Surgical Management of Subretinal Hemorrhage. , 2020, ss.1 - 9. 10.37845/ret.vit.2020.29.1 |
| AMA | James B,KARABAŞ V Surgical Management of Subretinal Hemorrhage. . 2020; 1 - 9. 10.37845/ret.vit.2020.29.1 |
| Vancouver | James B,KARABAŞ V Surgical Management of Subretinal Hemorrhage. . 2020; 1 - 9. 10.37845/ret.vit.2020.29.1 |
| IEEE | James B,KARABAŞ V "Surgical Management of Subretinal Hemorrhage." , ss.1 - 9, 2020. 10.37845/ret.vit.2020.29.1 |
| ISNAD | James, Braydon - KARABAŞ, V. Levent. "Surgical Management of Subretinal Hemorrhage". (2020), 1-9. https://doi.org/10.37845/ret.vit.2020.29.1 |
| APA | James B, KARABAŞ V (2020). Surgical Management of Subretinal Hemorrhage. Retina-Vitreus, 29(1), 1 - 9. 10.37845/ret.vit.2020.29.1 |
| Chicago | James Braydon,KARABAŞ V. Levent Surgical Management of Subretinal Hemorrhage. Retina-Vitreus 29, no.1 (2020): 1 - 9. 10.37845/ret.vit.2020.29.1 |
| MLA | James Braydon,KARABAŞ V. Levent Surgical Management of Subretinal Hemorrhage. Retina-Vitreus, vol.29, no.1, 2020, ss.1 - 9. 10.37845/ret.vit.2020.29.1 |
| AMA | James B,KARABAŞ V Surgical Management of Subretinal Hemorrhage. Retina-Vitreus. 2020; 29(1): 1 - 9. 10.37845/ret.vit.2020.29.1 |
| Vancouver | James B,KARABAŞ V Surgical Management of Subretinal Hemorrhage. Retina-Vitreus. 2020; 29(1): 1 - 9. 10.37845/ret.vit.2020.29.1 |
| IEEE | James B,KARABAŞ V "Surgical Management of Subretinal Hemorrhage." Retina-Vitreus, 29, ss.1 - 9, 2020. 10.37845/ret.vit.2020.29.1 |
| ISNAD | James, Braydon - KARABAŞ, V. Levent. "Surgical Management of Subretinal Hemorrhage". Retina-Vitreus 29/1 (2020), 1-9. https://doi.org/10.37845/ret.vit.2020.29.1 |
